A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors.
Saved in:
| Title: | A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors. |
|---|---|
| Authors: | Cote GM; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Kochupurakkal BS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Do K; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Bullock A; Harvard Medical School, Boston, Massachusetts.; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Cheng ML; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Muzikansky A; Mass General Cancer Center, Boston, Massachusetts., McLoughlin DE; Mass General Cancer Center, Boston, Massachusetts., Cleary JM; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gao X; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Parikh A; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Park JC; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Weekes CD; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Yeku O; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Zou L; Mass General Cancer Center, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Duke University, Durham, North Carolina., Shapiro GI; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Jan 06; Vol. 31 (1), pp. 35-44. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
